Last updated on November 2018

Safety Tolerability Pharmacokinetics and Efficacy of LMB763 in Patients With NASH


Brief description of study

The purpose of the present study is to assess the effects of LMB763 with respect to safety, tolerability, and on markers of liver inflammation in patients with NASH

Clinical Study Identifier: NCT02913105

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
San Juan, Puerto Rico
1.81miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.